Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 182 Neoplasms 115 Prostatic Neoplasms 103 Multiple Myeloma 85 Glioblastoma 82 Pancreatic Neoplasms 75 Glioma 65 Brain Neoplasms 60 Lung Neoplasms 58 Head and Neck Neoplasms 57 Melanoma 54 Colorectal Neoplasms 54 Carcinoma, Non-Small-Cell Lung 53 Leukemia, Myeloid, Acute 51 Carcinoma, Hepatocellular 50 Squamous Cell Carcinoma of Head and Neck 46 Recurrence 46 Ovarian Neoplasms 45 Lymphoma 39 Lymphoma, Non-Hodgkin 37 Lymphoma, B-Cell 36 Sarcoma 35 Stomach Neoplasms 34 Precursor Cell Lymphoblastic Leukemia-Lymphoma 34 Neoplasm Metastasis 33 Solid Tumor 31 Hematologic Neoplasms 31 Carcinoma, Renal Cell 30 Polycystic Ovary Syndrome 27 Burkitt Lymphoma 27

Interventions

selpercatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Cachexia-Anorexia Syndrome × Clear all

NCT07146893 2026-01-15

FEATHER

University of Oklahoma

Phase EARLY_PHASE1 Not yet recruiting

Cachexia-Anorexia Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡